1. Baak, J.P.A.; Path, F.R.C.; Hermsen, M.A.J.A.; Meijer, G.; Schmidt, J.; Janssen, E.A.M. Genomics and proteomics in cancer. Eur. J. Cancer 2003, 39 (9), 1199-1215.

2. Bastian, B.C.; LeBoit, P.E.; Hamm, H.; Broecker, E.-B.; Pinkel, D. Chromosomal gains and losses in primary cutaneous melanoma detected by comparative genomic hybridisation. Cancer Res. 1998, 58 (10), 2170-2175.

3. O'Hagan, R.C.; Brennan, C.W.; Strahs, A.; Zhang, X.; Kannan, K.; Donovan, M.; Cauwels, C.; Sharpless, N.E.; Wong, W.H.; Chin, L. Array comparative genome hybridisation for tumor classification and gene discovery in mouse models of malignant melanoma. Cancer Res. 2003, 63 (17), 5352-5356.

4. Ortonne, J.P. Photobiology and genetics of malignant melanoma. Br. J. Dermatol. 2002,146 (Suppl. 61), 11-16.

5. Omholt, K.; Platz, A.; Kanter, L.; Ringborg, U.; Hansson, J. NRAS and BRAF mutations arise early during melanoma pathogenesis and are preserved throughout tumor progression. Clin. Cancer Res. 2003, 9 (17), 6483-6488.

6. Goldberg, S.F.; Miele, M.E.; Hatta, N.; Takata, M.; Paquette-Straub, C.; Freedman, L.P.; Welch, D.R. Melanoma metastasis suppression by chromosome 6: Evidence for a pathway regulated by CRSP3 and TXNIP. Cancer Res. 2003, 63 (2), 432-440.

7. Baldi, A.; Santini, D.; De Luca, A.; Paggi, M.G. cDNA array technology in melanoma: An overview. J. Cell. Physiol. 2003, 196 (2), 219-223.

8. Vihinen, P.P.; Pyrhonen, S.O.; Kahari, V.M. New prognostic factors and developing therapy of cutaneous melanoma. Ann. Med. 2003, 35 (2), 66-78.

9. Bittner, M.; Meltzer, P.; Chen, Y.; Jiang, Y.; Seftor, E.; Hendrix, M.; Radmacher, M.; Simon, R.; Yakhini, Z.; Ben-Dor, A.; Sampas, N.; Dougherty, E.; Wang, E.; Marincola, F.; Gooden, C.; Lueders, J.; Glatfelter, A.; Pollock, P.; Carpten, J.; Gillanders, E.; Leja, D.; Dietrich, K.; Beaudry, C.; Berens, M.; Alberts, D.; Sondak, V. Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature 2000, 406 (6795), 536-540.

10. Hendrix, M.J.C.; Seftor, E.A.; Hess, A.R.; Seftor, R.E.B. Vascular mimicry and tumour-cell plasticity. Lessons from melanoma. Nat. Rev., Cancer 2003, 3 (6), 411-421.

11. Kallioniemi, O.P.; Wagner, U.; Kononen, J.; Sauter, G. Tissue microarray technology for high-throughput molecular profiling of cancer. Hum. Mol. Genet. 2001, 10 (7), 657-662.

12. Carr, K.M.; Bittner, M.; Trent, J.M. Gene-expression profiling in human cutaneous melanoma. Oncogene 2003, 22 (20), 3076-3080.

13. Balch, C.M.; Buzaid, A.C.; Soong, S.J.; Atkins, M.B.; Cascinelli, N.; Coit, D.G.; Fleming, I.D.; Gershenwald, J.E.; Houghton, A., Jr.; Kirkwood, J.M.; McMasters, K.M.; Mihm, M.F.; Morton, D.L.; Reintgen, D.S.; Ross, M.I.; Sober, A.; Thompson, J.A.; Thompson, J.F. Final version

How To Prevent Skin Cancer

How To Prevent Skin Cancer

Complete Guide to Preventing Skin Cancer. We all know enough to fear the name, just as we do the words tumor and malignant. But apart from that, most of us know very little at all about cancer, especially skin cancer in itself. If I were to ask you to tell me about skin cancer right now, what would you say? Apart from the fact that its a cancer on the skin, that is.

Get My Free Ebook

Post a comment